GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (STU:P0J) » Definitions » Institutional Ownership

Aptamer Group (STU:P0J) Institutional Ownership : 4.67% (As of Apr. 12, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Aptamer Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aptamer Group's institutional ownership is 4.67%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aptamer Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aptamer Group's Float Percentage Of Total Shares Outstanding is 0.00%.


Aptamer Group Institutional Ownership Historical Data

The historical data trend for Aptamer Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Institutional Ownership Chart

Aptamer Group Historical Data

The historical data trend for Aptamer Group can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.11 0.08 5.23 5.23 5.39 5.75 5.56 4.80 4.67 4.67

Aptamer Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Aptamer Group Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and other; Geographically earning maximum revenue from USA.

Aptamer Group Headlines

No Headlines